Technical Analysis for JAGX - Jaguar Animal Health, Inc.

Grade Last Price % Change Price Change
F 0.96 -1.90% -0.02
JAGX closed up 1.07 percent on Wednesday, November 20, 2024, on 51 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Calm After Storm Range Contraction -1.90%
Outside Day Range Expansion -1.90%
MACD Bullish Signal Line Cross Bullish -0.85%
Calm After Storm Range Contraction -0.85%
Calm After Storm Range Contraction -1.82%
NR7 Range Contraction -1.82%
Narrow Range Bar Range Contraction -1.82%
Inside Day Range Contraction -1.82%
Gapped Up Strength -1.82%
20 DMA Resistance Bearish 0.14%

   Recent Intraday Alerts

Alert Time
10 DMA Resistance about 1 hour ago
Up 1% about 1 hour ago
Down 2 % about 4 hours ago
Down 1% about 4 hours ago
Rose Above Previous Day's High 1 day ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Jaguar Animal Health, Inc. Description

Jaguar Animal Health, Inc., a development-stage animal health company, focuses on developing and commercializing gastrointestinal products for companion and production animals. The company's lead prescription drug product candidate includes Canalevia, a canine-specific formulation of Crofelemer for the treatment of CID and general acute watery diarrhea in dogs. It is also developing Crofelemer to treat acute colitis in horses and general acute watery diarrhea in cats; Neonorm, an enteric-coated tablet for scours in preweaned dairy calves, as well as other animal species, such as horses, goats, and sheep; and other product candidates, including Virend and NP-500. The company was founded in 2013 and is headquartered in San Francisco, California. Jaguar Animal Health, Inc. is a subsidiary of Napo Pharmaceuticals, Inc.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Gastrointestinal Animal Health Dog Gastroenterology Prescription Drugs Colitis Drug Products Diarrhea Gastrointestinal Tract Gastrointestinal Products

Is JAGX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 24.3
52 Week Low 0.9
Average Volume 280,286
200-Day Moving Average 4.26
50-Day Moving Average 1.13
20-Day Moving Average 1.03
10-Day Moving Average 0.99
Average True Range 0.09
RSI (14) 42.20
ADX 14.67
+DI 17.89
-DI 20.27
Chandelier Exit (Long, 3 ATRs) 0.94
Chandelier Exit (Short, 3 ATRs) 1.16
Upper Bollinger Bands 1.15
Lower Bollinger Band 0.91
Percent B (%b) 0.29
BandWidth 23.31
MACD Line -0.05
MACD Signal Line -0.05
MACD Histogram 0.0016
Fundamentals Value
Market Cap 49.74 Million
Num Shares 50.8 Million
EPS -0.87
Price-to-Earnings (P/E) Ratio -1.13
Price-to-Sales 0.46
Price-to-Book 3.12
PEG Ratio -0.02
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.11
Resistance 3 (R3) 1.11 1.06 1.09
Resistance 2 (R2) 1.06 1.03 1.06 1.08
Resistance 1 (R1) 1.02 1.00 1.04 1.02 1.08
Pivot Point 0.97 0.97 0.98 0.97 0.97
Support 1 (S1) 0.93 0.94 0.95 0.93 0.88
Support 2 (S2) 0.88 0.91 0.88 0.87
Support 3 (S3) 0.84 0.88 0.87
Support 4 (S4) 0.84